Additionally, our results also confirm that ROSA-mediated inhibition of TRPV3 leads to the downregulation of NF-κB pathway activity, thereby offering further mechanistic insight into the anti-inflammatory activity of ROSA and its analogs in alleviating skin inflammation. The gene discussed is TRPV3; the disease is dermatitis.